The antioxidant quercetin inhibits cellular proliferation via HIF-1-dependent induction of p21WAF

Antioxidants and Redox Signaling

Volumn 13, Issue 4, 2010, Pages 437-448

  Bach, Aline ^a   Bender Sigel, Julia ^a   Schrenk, Dieter ^a   Flügel, Daniela ^a,b   Kietzmann, Thomas ^a,b  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLOHEXIMIDE; DACTINOMYCIN; FLAVONOL DERIVATIVE; HYDROXYL GROUP; HYPOXIA INDUCIBLE FACTOR 1; PROLINE; QUERCETIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CYCLE; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HALF LIFE TIME; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROXYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TRANSACTIVATION;

ANTIOXIDANTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CALCIMYCIN; CELL LINE, TUMOR; CELL PROLIFERATION; CHELATING AGENTS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EGTAZIC ACID; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVANONES; FLAVONES; FLAVONOIDS; FLAVONOLS; HEP G2 CELLS; HT29 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUTEOLIN; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTEIN STABILITY; QUERCETIN; REACTIVE OXYGEN SPECIES;

EID: 77954482113     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.3000     Document Type: Article

References (49)

1. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, Kietzmann T, and Gorlach A. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 27: 755-761, 2007.
2. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E, and Keshet E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angio-genesis. Nature 394: 485-490, 1998.
3. Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H, and Poellinger L. Redox-regulated recruitment of the tran-scriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol Cell Biol 20: 402-415, 2000.
4. Chandel NS, Vander HM, Thompson CB, and Schumacker PT. Redox regulation of p53 during hypoxia. Oncogene 19: 3840-3848, 2000.
5. Du G, Lin H, Wang M, Zhang S, Wu X, Lu L, Ji L, and Yu L. Quercetin greatly improved therapeutic index of doxoru-bicin against 4T1 breast cancer by its opposing effects on HIF-1alpha in tumor and normal cells. Cancer Chemother Pharmacol 2009.
6. Ema M, Hirota K, Mimura J, Abe H, Yodoi J, Sogawa K, Poellinger L, and Fujii-Kuriyama Y. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP=p300. EMBO J 18: 1905-1914, 1999.
7. Goda N, Ryan HE, Khadivi B, McNulty W, Rickert RC, and Johnson RS. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol 23: 359-369, 2003.
8. Gong P, Hu B, Stewart D, Ellerbe M, Figueroa YG, Blank V, Beckman BS, and Alam J. Cobalt induces heme oxygenase-1 expression by a hypoxia-inducible factor-independent mechanism in Chinese hamster ovary cells: Regulation by Nrf2 and MafG transcription factors. JBiolChem 276: 27018-27025, 2001.
9. Gorlach A and Kietzmann T. Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors. Methods Enzymol 35: 421-446, 2007.
10. Hasebe Y, Egawa K, Yamazaki Y, Kunimoto S, Hirai Y, Ida Y, and Nose K. Specific inhibition of hypoxia-inducible factor (HIF)-1 alpha activation and of vascular endothelial growth factor (VEGF) production by flavonoids. Biol Pharm Bull 26: 1379-1383, 2003.
11. Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN, Welford RW, Elkins JM, Oldham NJ, Bhattacharya S, Gleadle JM, Ratcliffe PJ, Pugh CW, and Schofield CJ. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 277: 26351-26355, 2002.
12. Hirpara KV, Aggarwal P,Mukherjee AJ, Joshi N, and Burman AC. Quercetin and its derivatives: Synthesis, pharmacological uses with special emphasis on anti-tumor properties and prodrug with enhanced bio-availability. Anticancer Agents Med Chem 9: 138-161, 2009.
13. Huang LE, Arany Z, Livingston DM, and Bunn HF. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271: 32253-32259, 1996.
14. Iida T, Mine S, Fujimoto H, Suzuki K, Minami Y, and Tanaka Y. Hypoxia-inducible factor-1alpha induces cell cycle arrest of endothelial cells. Genes Cells 7: 143-149, 2002.
15. Jeon H, Kim H, Choi D, Kim D, Park SY, Kim YJ, Kim YM, and Jung Y. Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: A structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase. Mol Pharmacol 71: 1676-1684, 2007.
16. Jiang BH, Zheng JZ, Leung SW, Roe R, and Semenza GL. Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem 272: 19253-19260, 1997.
17. Kaelin WG. Proline hydroxylation and gene expression. Annu Rev Biochem 74: 115-128, 2005.
18. Kietzmann T, Cornesse Y, Brechtel K, Modaressi S, and Jungermann K. Perivenous expression of the mRNA of the three hypoxia-inducible factor alpha-subunits, HIF1alpha, HIF2alpha and HIF3alpha, in rat liver. Biochem J 354: 531-537, 2001.
19. Kietzmann T and Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol 16: 474-486, 2005.
20. Kietzmann T, Roth U, and Jungermann K. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia inducible factor-1 in rat hepatocytes. Blood 94: 4177-4185, 1999.
21. Knowles HJ, Raval RR, Harris AL, and Ratcliffe PJ. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res 63: 1764-1768, 2003.
22. Koivunen P, Hirsila M, Gunzler V, Kivirikko KI, and Myl-lyharju J. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem 279: 9899-9904, 2004.
23. Koong AC, Chen EY, and Giaccia AJ. Hypoxia causes the activation of nuclear factor kappa B through the phosphor-ylation of I kappa B alpha on tyrosine residues. Cancer Res 54: 1425-1430, 1994.
24. Kyle JA, Sharp L, Little J, Duthie GG, and McNeill G. Dietary flavonoid intake and colorectal cancer: A case-control study. Br J Nutr 1-8, 2009.
25. Lando D, Peet DJ, Whelan DA, Gorman J, and Whitelaw ML. Aspargine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295: 858-861, 2002.
26. Lee DH and Lee YJ. Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis. J Cell Biochem 105: 546-553, 2008.
27. Liu Q, Berchner-Pfannschmidt U, Moller U, Brecht M, Wotzlaw C, Acker H, Jungermann K, and Kietzmann T. A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc Natl Acad Sci USA 101: 4302-4307, 2004.
28. Liu Q, Moller U, Flugel D, and Kietzmann T. Induction of plasminogen activator inhibitor I gene expression by intra-cellular calcium via hypoxia-inducible factor-1. Blood 104: 3993-4001, 2004.
29. Mahon PC, Hirota K, and Semenza GL. FIH-1: A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15: 2675-2686, 2001.
30. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, and Semenza GL. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105: 659-669, 2005.
31. Neuhouser ML. Dietary flavonoids and cancer risk: Evidence from human population studies. Nutr Cancer 50: 1-7, 2004.
32. Page EL, Chan DA, Giaccia AJ, Levine M, and Richard DE. Hypoxia-inducible factor-1{alpha} stabilization in nonhy-poxic conditions: Role of oxidation and intracellular ascor-bate depletion. Mol Biol Cell 19: 86-94: 2008.
33. Park SS, Bae I, and Lee YJ. Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha=2alpha is mediated through chelation of iron. J Cell Biochem 103: 1089-1998, 2007.
34. Pohl C, Will F, Dietrich H, and Schrenk D,. Cytochrome P450 1A1 expression and activity in Caco-2 cells: Modulation by apple juice extract and certain apple polyphenols. J Agric Food Chem 54: 10262-10268, 2006.
35. Pugh CW, O'Rourke JF, Nagao M, Gleadle JM, and Ratcliffe PJ. Activation of hypoxia-inducible factor-1; Definition of regulatory domains within the alpha subunit. J Biol Chem 272: 11205-11214, 1997.
36. Salnikow K, Costa M, Figg WD, and Blagosklonny MV. Hyperinducibility of hypoxia-responsive genes without p53=p21-dependent checkpoint in aggressive prostate cancer. Cancer Res 60: 5630-5634, 2000.
37. Schofield CJ and Ratcliffe PJ. Signalling hypoxia by HIF hy-droxylases. Biochem Biophys Res Commun 338: 617-626, 2005.
38. Semenza GL. HIF-1 and tumor progression: Pathophysiol-ogy and therapeutics. Trends Mol Med 8: S62-S67, 2002.
39. Triantafyllou A, Liakos P, Tsakalof A, Chachami G, Para-skeva E, Molyvdas PA, Georgatsou E, Simos G, and Bonanou S. The flavonoid quercetin induces hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits cell proliferation by depleting intracellular iron. Free Radic Res 41: 342-356, 2007.
40. Triantafyllou A, Mylonis I, Simos G, Bonanou S, and Tsakalof A. Flavonoids induce HIF-1alpha but impair its nuclear accumulation and activity. Free Radic Biol Med 44: 657-670, 2008.
41. Wang Y, Shen J, Arenzana N, Tirasophon W, Kaufman RJ, and Prywes R. Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. J Biol Chem 275: 27013-27020, 2000.
42. Wenger RH and Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 378: 609-616, 1997.
43. Wenger RH, Stiehl DP, and Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005: re12, 2005.
44. Wiener CM, Booth G, and Semenza GL. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 225: 485-488, 1996.
45. Williams RJ, Spencer JP, and Rice-Evans C. Flavonoids: Antioxidants or signalling molecules? Free Radic Biol Med 36: 838-849, 2004.
46. Wilson WJ and Poellinger L. The dietary flavonoid quercetin modulates HIF-1 alpha activity in endothelial cells. Biochem Biophys Res Commun 293: 446-450, 2002.
47. Yang CS, Landau JM, Huang MT, and Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21: 381-406, 2001.
48. Yu AY, Frid MG, Shimoda LA, Wiener CM, Stenmark K, and Semenza GL, Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol 275: L818-L826, 1998.
49. Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, and Semenza GL, Expression of hypoxia-inducible factor 1alpha in brain tumors: Association with angiogenesis, invasion, and progression. Cancer 88: 2606-2618, 2000.